Novartis AG
Healthcare
16 December, 2019
Cipla acquires India trademark rights for anti-diabetic drug from Novartis
Indian pharmaceutical major Cipla Ltd has acquired the brand name and trademark rights for Vysov and Vysov M (Vildagliptin and ......
Healthcare
04 December, 2019
Eris Lifesciences buys anti-diabetic drug from Novartis for India market
Eris Lifesciences Ltd said it has acquired the trademark for anti-diabetic drug Zomelis for $13 million (Rs 92.9 crore) from ......
General
07 May, 2018
Patanjali top bidder for Ruchi Soya; Aurobindo eyes Novartis' generics biz
Patanjali Ayurved Ltd, the fast-moving consumer goods firm run by yoga guru Baba Ramdev, has made a Rs 4,000-4,500-crore bid ......
Healthcare
05 October, 2017
Samara Capital acquires several brands from Novartis
Private equity firm Samara Capital Partners Pvt. Ltd has acquired several brands in the women’s health segment from global pharmaceutical ......